Poland· PL-100470533

Beto 25 ZK

A metoprolol product containing metoprololi succinas, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC C07AB02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBeto 25 ZKATCC07AB02REGISTER NO.PL-100470533PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Metoprolol is registered in 19 of 19 countries.

Countries holding a registration under ATC C07AB02 (metoprolol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Metoprolol · ATC C07AB02

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of metoprolol costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.11 in Spain to $0.91 in Switzerland — a ×8.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Metoprolol · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.91
  • IT Italy$0.17
  • FR France$0.15
  • ES Spain$0.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Metoprololi succinas
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
C07AB02
ATC class
Metoprolol
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991487119
  • gtin
    05909991487126

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

508 interactions on record for metoprolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metoprolol · interactions on record

508 records

  • 11 severe
  • 213 moderate
  • 22 minor
  • 203 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe

59 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Metoprolol in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metoprolol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Beloc, Lanoc
  • Belgium · Metoprolol Eg, Metoprolol Retard Teva
  • Bulgaria · Betablockade 100 Mg, Betablockade 50 Mg
  • Cyprus · Betaloc Zok, Bloxazoc
  • Czechia · Betaloc, Betaloc Sr
  • Germany · Beloc I.V., Beloc-Zok
  • Denmark · Bloxazoc, Metocar
  • Estonia · Betaloc, Betaloc Zok
  • Spain · Beloken, Lopresor
  • Finland · Metohexal, Metomylan
  • France · Lopressor, Lopressor Lp
  • United Kingdom (Northern Ireland) · Betaloc I.V, Metoprolol Tartrate Accord Healthcare
  • Greece · Lopresor, Metazero Xr
  • Croatia · Betaloc Zok, Bloxan
  • Hungary · Betaloc, Betaloc Zok
  • Ireland · Betaloc, Metocor
  • Iceland · Bloxazoc, Metoprolol Alvogen
  • Italy · Lopresor, Metoprololo Aurobindo
  • Lithuania · Betaloc, Betaloc Zok
  • Luxembourg · Seloken, Seloken I.V.
  • Latvia · Betaloc, Betaloc Zok
  • Malta · Metocor, Metoprolol Aurobindo
  • Netherlands · Metoprolol Succinate Aurobindo, Metoprololsuccinaat Retard Viatris
  • Norway · Bloxazoc, Metomylan
  • Portugal · Lopresor, Metoprolol Aurobindo
  • Romania · Betaloc, Betaloc Zok
  • Sweden · Bloxazoc, Metomylan
  • Slovenia · Bloxan, Bloxazoc
  • Slovakia · Betaloc, Betaloc Zok

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b0c986a3-e2b6-41ff-8e96-732a2e4fb5d7
GET /v1/drugs/b0c986a3-e2b6-41ff-8e96-732a2e4fb5d7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "23,75 mg",
  "packaging": "05909991487119 ¦ Rp ¦ 145565\n30 tabl.\n05909991487126 ¦ Rp ¦ 145566\n60 tabl.",
  "substance": "Metoprololi succinas 23.75 mg",
  "common_name": "Metoprololi succinas",
  "pl_product_id": "100470533",
  "pozwolenie_nr": "269/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-06-29"
}

See everything about metoprolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.